Page last updated: 2024-12-08

ethynylpyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethynylpyridine: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID137268
CHEMBL ID5201133
SCHEMBL ID211092
MeSH IDM0494857

Synonyms (29)

Synonym
AKOS008901246
2-ethynyl pyridine
pyridine, 2-ethynyl-
inchi=1/c7h5n/c1-2-7-5-3-4-6-8-7/h1,3-6
2-ethynylpyridine
2-ethynylpyridine, 98%
1945-84-2
2-pyridylacetylene
E0340
2-ethynyl-pyridine
A813735
BP-13009
FT-0612298
AM20061684
PB17077
SCHEMBL211092
SY019272
mfcd00041598
ortho-ethynylpyridine
ethynyl pyridine
ethynylpyridine
2-(ethynyl)pyridine
pyridine, ethynyl-
PS-9306
DTXSID40173085
J-509347
CS-W002197
CHEMBL5201133
EN300-96035
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1887063Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability incubated for 3 days by methylene blue staining based analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis.
AID1887064Cytotoxicity against human NCI-H522 cells assessed as reduction in cell viability incubated for 3 days by methylene blue staining based analysis2022Journal of medicinal chemistry, 09-08, Volume: 65, Issue:17
Tunable Cysteine-Targeting Electrophilic Heteroaromatic Warheads Induce Ferroptosis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (12.50)29.6817
2010's12 (75.00)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.57 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.06 (4.65)
Search Engine Demand Index39.96 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]